Halsey Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Halsey Associates's PFE Position: Q3 2019 in Review
Halsey Associates increased its Pfizer (PFE) stake by 74% in Q3 2019, buying an estimated $721K and bringing the position to 46,709 shares worth $1.59M. The position accounts for 0.25% of the portfolio, ranked #56.
Halsey Associates first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.97M in Q4 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Halsey Associates held 46,709 shares of Pfizer worth $1.59M as of Q3 2019.
- Halsey Associates bought 19,838 Pfizer shares in Q3 2019, an estimated $721K.
- Pfizer made up 0.25% of Halsey Associates's portfolio in Q3 2019, its #56 holding.
- Halsey Associates first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
- Halsey Associates's Pfizer position peaked at $1.97M in Q4 2018.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.